RBC Trims Price Target on Illumina to $252 From $254, Keeps Outperform Rating
Citi Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $190
Stephens & Co. Maintains Overweight on Illumina, Raises Price Target to $184
Stephens Maintains Illumina(ILMN.US) With Buy Rating, Raises Target Price to $184
Morgan Stanley Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $156
Illumina Is Maintained at Overweight by Piper Sandler
Illumina Analyst Ratings
Piper Sandler Maintains Illumina(ILMN.US) With Buy Rating, Cuts Target Price to $185
Scotiabank Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $164
Illumina (ILMN) Receives a Buy From Scotiabank
JP Morgan Maintains Neutral on Illumina, Raises Price Target to $140
Stifel Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $160
Illumina Is Maintained at Hold by Canaccord Genuity
Illumina Price Target Raised to $145.00/Share From $130.00 by Canaccord Genuity
A Quick Look at Today's Ratings for Illumina(ILMN.US), With a Forecast Between $177 to $254
Illumina Analyst Ratings
Barclays Reaffirms Their Hold Rating on Illumina (ILMN)
RBC Capital Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $252
Leerink Partners Maintains Illumina(ILMN.US) With Buy Rating, Raises Target Price to $200
Illumina Analyst Ratings